{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:51:49Z","timestamp":1794019909459,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB-ILP-POR-2019-004"],"award-info":[{"award-number":["HRB-ILP-POR-2019-004"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB-ILP-POR-2019-004"],"award-info":[{"award-number":["HRB-ILP-POR-2019-004"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB-ILP-POR-2019-004"],"award-info":[{"award-number":["HRB-ILP-POR-2019-004"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB-ILP-POR-2019-004"],"award-info":[{"award-number":["HRB-ILP-POR-2019-004"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020425","name":"Irish Thoracic Society","doi-asserted-by":"publisher","award":["MRCG-2018-16"],"award-info":[{"award-number":["MRCG-2018-16"]}],"id":[{"id":"10.13039\/501100020425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020425","name":"Irish Thoracic Society","doi-asserted-by":"publisher","award":["MRCG-2018-16"],"award-info":[{"award-number":["MRCG-2018-16"]}],"id":[{"id":"10.13039\/501100020425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020425","name":"Irish Thoracic Society","doi-asserted-by":"publisher","award":["MRCG-2018-16"],"award-info":[{"award-number":["MRCG-2018-16"]}],"id":[{"id":"10.13039\/501100020425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020425","name":"Irish Thoracic Society","doi-asserted-by":"publisher","award":["MRCG-2018-16"],"award-info":[{"award-number":["MRCG-2018-16"]}],"id":[{"id":"10.13039\/501100020425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1183640"],"award-info":[{"award-number":["APP1183640"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1183640"],"award-info":[{"award-number":["APP1183640"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1183640"],"award-info":[{"award-number":["APP1183640"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["TECNIOspring PLUS 712949"],"award-info":[{"award-number":["TECNIOspring PLUS 712949"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agency for Business Competitiveness of the Government of Catalonia","award":["TECSPR18-1-0056"],"award-info":[{"award-number":["TECSPR18-1-0056"]}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["OGARA1710"],"award-info":[{"award-number":["OGARA1710"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["STICK10K0"],"award-info":[{"award-number":["STICK10K0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["OGARA1710"],"award-info":[{"award-number":["OGARA1710"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Comission","doi-asserted-by":"crossref","award":["EU-634486"],"award-info":[{"award-number":["EU-634486"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Comission","doi-asserted-by":"crossref","award":["EU-634486"],"award-info":[{"award-number":["EU-634486"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SSPC-2\/PharM5"],"award-info":[{"award-number":["SSPC-2\/PharM5"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SSPC-2\/PharM5"],"award-info":[{"award-number":["SSPC-2\/PharM5"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Enterprise Ireland Commercialisation Fund","award":["CF-2017-0757-P"],"award-info":[{"award-number":["CF-2017-0757-P"]}]},{"name":"Enterprise Ireland Commercialisation Fund","award":["CF-2017-0757-P"],"award-info":[{"award-number":["CF-2017-0757-P"]}]},{"name":"The Institute for Respiratory Health","award":["Glenn Brown Memorial Grant 2017"],"award-info":[{"award-number":["Glenn Brown Memorial Grant 2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cystic Fibrosis (CF) is a genetic condition characterized by neutrophilic inflammation and recurrent infection of the airways. How these processes are initiated and perpetuated in CF remains largely unknown. We have demonstrated a link between the intestinal microbiota-related metabolites bile acids (BA) and inflammation in the bronchoalveolar lavage fluid (BALF) from children with stable CF lung disease. To establish if BA indicate early pathological processes in CF lung disease, we combined targeted mass spectrometry and amplicon sequencing-based microbial characterization of 121 BALF specimens collected from 12-month old infants with CF enrolled in the COMBAT-CF study, a multicentre randomized placebo-controlled clinical trial comparing azithromycin versus placebo. We evaluated whether detection of BA in BALF is associated with the establishment of the inflammatory and microbial landscape of early CF lung disease, and whether azithromycin, a motilin agonist that has been demonstrated to reduce aspiration of gastric contents, alters the odds of detecting BA in BALF. We also explored how different prophylactic antibiotics regimens impact the early life BALF microbiota.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Detection of BA in BALF was strongly associated with biomarkers of airway inflammation, more exacerbation episodes during the first year of life, increased use of oral antibiotics with prolonged treatment periods, a higher degree of structural lung damage, and distinct microbial profiles. Treatment with azithromycin, a motilin agonist, which has been reported to reduce aspiration of gastric contents, did not reduce the odds of detecting BA in BALF. Culture and molecular methods showed that azithromycin does not alter bacterial load or diversity in BALF. Conversely, penicillin-type prophylaxis reduced the odds of detecting BAs in BALF, which was associated with elevated levels of circulating biomarkers of cholestasis. We also observed that environmental factors such as penicillin-type prophylaxis or BAs detection were linked to distinct early microbial communities of the CF airways, which were associated with different inflammatory landscapes but not with structural lung damage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Detection of BA in BALF portend early pathological events in CF lung disease. Benefits early in life associated with azithromycin are not linked to its antimicrobial properties.<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1186\/s40168-023-01543-9","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T09:01:59Z","timestamp":1686646919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis"],"prefix":"10.1186","volume":"11","author":[{"given":"Jose A.","family":"Caparr\u00f3s-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Saladie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Patricia","family":"Agudelo-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Jerry","family":"Reen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Sly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Stick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal","family":"O\u2019Gara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COMBAT study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"issue":"10059","key":"1543_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(16)00576-6.","journal-title":"Lancet"},{"issue":"12","key":"1543_CR2","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1164\/rccm.201606-1107CI","volume":"195","author":"SC Ranganathan","year":"2017","unstructured":"Ranganathan SC, Hall GL, Sly PD, Stick SM, Douglas TA, Australian Respiratory Early Surveillance Team for Cystic F. Early lung disease in infants and preschool children with cystic fibrosis. What have we learned and what should we do about it? Am J Respir Crit Care Med. 2017;195(12):1567\u201375. https:\/\/doi.org\/10.1164\/rccm.201606-1107CI.","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"1543_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","volume":"368","author":"PD Sly","year":"2013","unstructured":"Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med. 2013;368(21):1963\u201370. https:\/\/doi.org\/10.1056\/NEJMoa1301725.","journal-title":"N Engl J Med"},{"issue":"486","key":"1543_CR4","doi-asserted-by":"publisher","first-page":"eaav3488","DOI":"10.1126\/scitranslmed.aav3488","volume":"11","author":"CR Esther Jr","year":"2019","unstructured":"Esther CR Jr, Muhlebach MS, Ehre C, Hill DB, Wolfgang MC, Kesimer M, et al. Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis. Sci Transl Med. 2019;11(486):eaav3488. https:\/\/doi.org\/10.1126\/scitranslmed.aav3488.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1543_CR5","doi-asserted-by":"publisher","first-page":"1600903","DOI":"10.1183\/13993003.00903-2016","volume":"49","author":"ST Montgomery","year":"2017","unstructured":"Montgomery ST, Mall MA, Kicic A, Stick SM, Arest CF. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J. 2017;49(1):1600903. https:\/\/doi.org\/10.1183\/13993003.00903-2016.","journal-title":"Eur Respir J"},{"issue":"5","key":"1543_CR6","doi-asserted-by":"publisher","first-page":"1700832","DOI":"10.1183\/13993003.00832-2017","volume":"50","author":"ET Zemanick","year":"2017","unstructured":"Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, et al. Airway microbiota across age and disease spectrum in cystic fibrosis. Eur Respir J. 2017;50(5):1700832. https:\/\/doi.org\/10.1183\/13993003.00832-2017.","journal-title":"Eur Respir J"},{"issue":"11","key":"1543_CR7","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/pnas.0712386105","volume":"105","author":"R Tirouvanziam","year":"2008","unstructured":"Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A. 2008;105(11):4335\u20139. https:\/\/doi.org\/10.1073\/pnas.0712386105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1543_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40168-020-00810-3","volume":"8","author":"L Cuthbertson","year":"2020","unstructured":"Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, et al. Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020;8(1):45. https:\/\/doi.org\/10.1186\/s40168-020-00810-3.","journal-title":"Microbiome"},{"issue":"4","key":"1543_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/ajrccm\/151.4.1075","volume":"151","author":"TZ Khan","year":"1995","unstructured":"Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151(4):1075\u201382. https:\/\/doi.org\/10.1164\/ajrccm\/151.4.1075.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1543_CR10","doi-asserted-by":"publisher","first-page":"1801771","DOI":"10.1183\/13993003.01771-2018","volume":"54","author":"T Rosenow","year":"2019","unstructured":"Rosenow T, Mok LC, Turkovic L, Berry LJ, Sly PD, Ranganathan S, et al. The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis. Eur Respir J. 2019;54(1):1801771. https:\/\/doi.org\/10.1183\/13993003.01771-2018.","journal-title":"Eur Respir J"},{"issue":"7","key":"1543_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1164\/rccm.201803-0442OC","volume":"199","author":"C Margaroli","year":"2019","unstructured":"Margaroli C, Garratt LW, Horati H, Dittrich AS, Rosenow T, Montgomery ST, et al. Elastase exocytosis by airway neutrophils is associated with early lung damage in children with cystic fibrosis. Am J Respir Crit Care Med. 2019;199(7):873\u201381. https:\/\/doi.org\/10.1164\/rccm.201803-0442OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1543_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/diagnostics10050282","volume":"10","author":"JA Caparros-Martin","year":"2020","unstructured":"Caparros-Martin JA, Flynn S, Reen FJ, Woods DF, Agudelo-Romero P, Ranganathan SC, et al. The detection of bile acids in the lungs of paediatric cystic fibrosis patients is associated with altered inflammatory patterns. Diagnostics (Basel). 2020;10(5):282. https:\/\/doi.org\/10.3390\/diagnostics10050282.","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"1543_CR13","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/microorganisms8111741","volume":"8","author":"S Flynn","year":"2020","unstructured":"Flynn S, Reen FJ, Caparros-Martin JA, Woods DF, Peplies J, Ranganathan SC, et al. Bile acid signal molecules associate temporally with respiratory inflammation and microbiome signatures in clinically stable cystic fibrosis patients. Microorganisms. 2020;8(11):1741. https:\/\/doi.org\/10.3390\/microorganisms8111741.","journal-title":"Microorganisms"},{"issue":"1","key":"1543_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstrom","year":"2016","unstructured":"Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.005.","journal-title":"Cell Metab"},{"issue":"20","key":"1543_CR15","doi-asserted-by":"publisher","first-page":"e0031121","DOI":"10.1128\/JB.00311-21","volume":"203","author":"CE Price","year":"2021","unstructured":"Price CE, O\u2019Toole GA. The gut-lung axis in cystic fibrosis. J Bacteriol. 2021;203(20):e0031121. https:\/\/doi.org\/10.1128\/JB.00311-21.","journal-title":"J Bacteriol"},{"key":"1543_CR16","doi-asserted-by":"publisher","unstructured":"Stick SM, Foti A, Ware RS, Tiddens H, Clements BS, Armstrong DS, et al. The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial. Lancet Respir Med. 2022;10(8):776-84. https:\/\/doi.org\/10.1016\/S2213-2600(22)00165-5.","DOI":"10.1016\/S2213-2600(22)00165-5"},{"issue":"8","key":"1543_CR17","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/bph.12077","volume":"168","author":"J Broad","year":"2013","unstructured":"Broad J, Sanger GJ. The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. Br J Pharmacol. 2013;168(8):1859\u201367. https:\/\/doi.org\/10.1111\/bph.12077.","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1543_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1164\/rccm.201501-0061OC","volume":"191","author":"T Rosenow","year":"2015","unstructured":"Rosenow T, Oudraad MC, Murray CP, Turkovic L, Kuo W, de Bruijne M, et al. PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med. 2015;191(10):1158\u201365. https:\/\/doi.org\/10.1164\/rccm.201501-0061OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1543_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/mmy.41.2.149.161","volume":"41","author":"W Buzina","year":"2003","unstructured":"Buzina W, Braun H, Freudenschuss K, Lackner A, Habermann W, Stammberger H. Fungal biodiversity\u2013as found in nasal mucus. Med Mycol. 2003;41(2):149\u201361. https:\/\/doi.org\/10.1080\/mmy.41.2.149.161.","journal-title":"Med Mycol"},{"key":"1543_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/2049-2618-2-40","volume":"2","author":"SD Willger","year":"2014","unstructured":"Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, Morrison HG, et al. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome. 2014;2:40. https:\/\/doi.org\/10.1186\/2049-2618-2-40.","journal-title":"Microbiome"},{"issue":"7454","key":"1543_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature12171","volume":"498","author":"K Findley","year":"2013","unstructured":"Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498(7454):367\u201370. https:\/\/doi.org\/10.1038\/nature12171.","journal-title":"Nature"},{"issue":"1","key":"1543_CR22","doi-asserted-by":"publisher","first-page":"13016","DOI":"10.1038\/s41598-017-13270-x","volume":"7","author":"A Boix-Amoros","year":"2017","unstructured":"Boix-Amoros A, Martinez-Costa C, Querol A, Collado MC, Mira A. Multiple approaches detect the presence of fungi in human breastmilk samples from healthy mothers. Sci Rep. 2017;7(1):13016. https:\/\/doi.org\/10.1038\/s41598-017-13270-x.","journal-title":"Sci Rep"},{"issue":"3","key":"1543_CR23","doi-asserted-by":"publisher","first-page":"e90899","DOI":"10.1371\/journal.pone.0090899","volume":"9","author":"AK Dupuy","year":"2014","unstructured":"Dupuy AK, David MS, Li L, Heider TN, Peterson JD, Montano EA, et al. Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS One. 2014;9(3):e90899. https:\/\/doi.org\/10.1371\/journal.pone.0090899.","journal-title":"PLoS One"},{"issue":"2","key":"1543_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.chom.2017.07.002","volume":"22","author":"JJ Limon","year":"2017","unstructured":"Limon JJ, Skalski JH, Underhill DM. Commensal fungi in health and disease. Cell Host Microbe. 2017;22(2):156\u201365. https:\/\/doi.org\/10.1016\/j.chom.2017.07.002.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"1543_CR25","doi-asserted-by":"publisher","first-page":"e30126","DOI":"10.1371\/journal.pone.0030126","volume":"7","author":"I Holmes","year":"2012","unstructured":"Holmes I, Harris K, Quince C. Dirichlet multinomial mixtures: generative models for microbial metagenomics. PLoS One. 2012;7(2):e30126. https:\/\/doi.org\/10.1371\/journal.pone.0030126.","journal-title":"PLoS One"},{"issue":"12","key":"1543_CR26","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/gutjnl-2011-300926","volume":"61","author":"WO Rohof","year":"2012","unstructured":"Rohof WO, Bennink RJ, de Ruigh AA, Hirsch DP, Zwinderman AH, Boeckxstaens GE. Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period. Gut. 2012;61(12):1670\u20137. https:\/\/doi.org\/10.1136\/gutjnl-2011-300926.","journal-title":"Gut"},{"issue":"4","key":"1543_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5056\/jnm.2010.16.4.407","volume":"16","author":"JM Larson","year":"2010","unstructured":"Larson JM, Tavakkoli A, Drane WE, Toskes PP, Moshiree B. Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis. J Neurogastroenterol Motil. 2010;16(4):407\u201313. https:\/\/doi.org\/10.5056\/jnm.2010.16.4.407.","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"1543_CR28","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011;53(4):1377\u201387. https:\/\/doi.org\/10.1002\/hep.24229.","journal-title":"Hepatology"},{"issue":"12","key":"1543_CR29","doi-asserted-by":"publisher","first-page":"e00434","DOI":"10.14309\/ctg.0000000000000434","volume":"12","author":"R Rosen","year":"2021","unstructured":"Rosen R, Lurie M, Kane M, DiFilippo C, Cohen A, Freiberger D, et al. Risk factors for bile aspiration and its impact on clinical outcomes. Clin Transl Gastroenterol. 2021;12(12):e00434. https:\/\/doi.org\/10.14309\/ctg.0000000000000434.","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"1543_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jcf.2021.05.016","volume":"20","author":"S Henen","year":"2021","unstructured":"Henen S, Denton C, Teckman J, Borowitz D, Patel D. Review of gastrointestinal motility in cystic fibrosis. J Cyst Fibros. 2021;20(4):578\u201385. https:\/\/doi.org\/10.1016\/j.jcf.2021.05.016.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"1543_CR31","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.chest.2020.06.044","volume":"158","author":"A Ishak","year":"2020","unstructured":"Ishak A, Stick SM, Turkovic L, Ranganathan SC, King L, Harrison J, et al. BAL inflammatory markers can predict pulmonary exacerbations in children with cystic fibrosis. Chest. 2020;158(6):2314\u201322. https:\/\/doi.org\/10.1016\/j.chest.2020.06.044.","journal-title":"Chest"},{"issue":"9944","key":"1543_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0140-6736(14)61136-3","volume":"384","author":"RP Dickson","year":"2014","unstructured":"Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384(9944):691\u2013702. https:\/\/doi.org\/10.1016\/S0140-6736(14)61136-3.","journal-title":"Lancet"},{"issue":"9","key":"1543_CR33","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1164\/rccm.202005-1596OC","volume":"203","author":"BG Wu","year":"2021","unstructured":"Wu BG, Sulaiman I, Tsay JJ, Perez L, Franca B, Li Y, et al. Episodic aspiration with oral commensals induces a MyD88-dependent, pulmonary T-Helper cell type 17 response that mitigates susceptibility to streptococcus pneumoniae. Am J Respir Crit Care Med. 2021;203(9):1099\u2013111. https:\/\/doi.org\/10.1164\/rccm.202005-1596OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1543_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1128\/mBio.02287-16","volume":"8","author":"RP Dickson","year":"2017","unstructured":"Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Falkowski NR, Huffnagle GB, et al. Bacterial topography of the healthy human lower respiratory tract. mBio. 2017;8(1):87\u201316. https:\/\/doi.org\/10.1128\/mBio.02287-16.","journal-title":"mBio"},{"issue":"4","key":"1543_CR35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.celrep.2019.03.086","volume":"27","author":"P Jorth","year":"2019","unstructured":"Jorth P, Ehsan Z, Rezayat A, Caldwell E, Pope C, Brewington JJ, et al. Direct lung sampling indicates that established pathogens dominate early infections in children with cystic fibrosis. Cell Rep. 2019;27(4):1190-204 e3. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.086.","journal-title":"Cell Rep"},{"issue":"10","key":"1543_CR36","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1513\/AnnalsATS.201702-121OC","volume":"14","author":"JE Pittman","year":"2017","unstructured":"Pittman JE, Wylie KM, Akers K, Storch GA, Hatch J, Quante J, et al. Association of antibiotics, airway microbiome, and inflammation in infants with cystic fibrosis. Ann Am Thorac Soc. 2017;14(10):1548\u201355. https:\/\/doi.org\/10.1513\/AnnalsATS.201702-121OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"1543_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12866-021-02159-5","volume":"21","author":"N Acosta","year":"2021","unstructured":"Acosta N, Thornton CS, Surette MG, Somayaji R, Rossi L, Rabin HR, et al. Azithromycin and the microbiota of cystic fibrosis sputum. BMC Microbiol. 2021;21(1):96. https:\/\/doi.org\/10.1186\/s12866-021-02159-5.","journal-title":"BMC Microbiol"},{"issue":"3","key":"1543_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.201911-2202OC","volume":"202","author":"M Mac Aogain","year":"2020","unstructured":"Mac Aogain M, Lau KJX, Cai Z, Kumar Narayana J, Purbojati RW, Drautz-Moses DI, et al. Metagenomics reveals a core macrolide resistome related to microbiota in chronic respiratory disease. Am J Respir Crit Care Med. 2020;202(3):433\u201347. https:\/\/doi.org\/10.1164\/rccm.201911-2202OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1543_CR39","doi-asserted-by":"publisher","first-page":"572504","DOI":"10.3389\/fmicb.2020.572504","volume":"11","author":"M Saladie","year":"2020","unstructured":"Saladie M, Caparros-Martin JA, Agudelo-Romero P, Wark PAB, Stick S, O\u2019Gara F. Microbiomic analysis on low abundant respiratory biomass samples; improved recovery of microbial DNA from bronchoalveolar lavage fluid. Front Microbiol. 2020;11:572504. https:\/\/doi.org\/10.3389\/fmicb.2020.572504.","journal-title":"Front Microbiol"},{"issue":"1","key":"1543_CR40","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1. https:\/\/doi.org\/10.1093\/nar\/gks808.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1543_CR41","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590-6. https:\/\/doi.org\/10.1093\/nar\/gks1219.","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"1543_CR42","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/bioinformatics\/bts252","volume":"28","author":"E Pruesse","year":"2012","unstructured":"Pruesse E, Peplies J, Glockner FO. SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes. Bioinformatics. 2012;28(14):1823\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/bts252.","journal-title":"Bioinformatics"},{"key":"1543_CR43","doi-asserted-by":"publisher","first-page":"e2584","DOI":"10.7717\/peerj.2584","volume":"18","author":"T Rognes","year":"2016","unstructured":"Rognes T, Flouri T, Nichols B, Quince C, Mahe F. VSEARCH: a versatile open source tool for metagenomics. Peer J. 2016;18:e2584. https:\/\/doi.org\/10.7717\/peerj.2584.","journal-title":"Peer J"},{"issue":"7","key":"1543_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u20133. https:\/\/doi.org\/10.1038\/nmeth.3869.","journal-title":"Nat Methods"},{"key":"1543_CR45","doi-asserted-by":"publisher","unstructured":"Abarenkov K, Zirk A, Piirmann T, P\u00f6h\u00f6nen R, Ivanov F, Nilsson RH, et al. UNITE general FASTA release for Fungi. UNITE Community.\u00a02020. https:\/\/doi.org\/10.15156\/BIO\/786368.","DOI":"10.15156\/BIO\/786368"},{"issue":"16","key":"1543_CR46","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261\u20137. https:\/\/doi.org\/10.1128\/AEM.00062-07.","journal-title":"Appl Environ Microbiol"},{"key":"1543_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41479-018-0051-8","volume":"10","author":"RL Marsh","year":"2018","unstructured":"Marsh RL, Nelson MT, Pope CE, Leach AJ, Hoffman LR, Chang AB, et al. How low can we go? The implications of low bacterial load in respiratory microbiota studies. Pneumonia (Nathan). 2018;10:7. https:\/\/doi.org\/10.1186\/s41479-018-0051-8.","journal-title":"Pneumonia (Nathan)"},{"issue":"2","key":"1543_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer R, Minich JJ, Marotz C, Cooper A, Knight R, Weyrich LS. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 2019;27(2):105\u201317. https:\/\/doi.org\/10.1016\/j.tim.2018.11.003.","journal-title":"Trends Microbiol"},{"issue":"6","key":"1543_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00284-017-1237-7","volume":"74","author":"A Ilahi","year":"2017","unstructured":"Ilahi A, Hadrich I, Neji S, Trabelsi H, Makni F, Ayadi A. Real-time PCR identification of six malassezia species. Curr Microbiol. 2017;74(6):671\u20137. https:\/\/doi.org\/10.1007\/s00284-017-1237-7.","journal-title":"Curr Microbiol"},{"issue":"1","key":"1543_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40168-017-0312-4","volume":"5","author":"JA Caparros-Martin","year":"2017","unstructured":"Caparros-Martin JA, Lareu RR, Ramsay JP, Peplies J, Reen FJ, Headlam HA, et al. Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism. Microbiome. 2017;5(1):95. https:\/\/doi.org\/10.1186\/s40168-017-0312-4.","journal-title":"Microbiome"},{"issue":"1","key":"1543_CR51","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","volume":"11","author":"H Lin","year":"2020","unstructured":"Lin H, Peddada SD. Analysis of compositions of microbiomes with bias correction. Nat Commun. 2020;11(1):3514. https:\/\/doi.org\/10.1038\/s41467-020-17041-7.","journal-title":"Nat Commun"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-023-01543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-023-01543-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-023-01543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T09:22:26Z","timestamp":1686648146000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-023-01543-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1543"],"URL":"https:\/\/doi.org\/10.1186\/s40168-023-01543-9","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"22 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This ancillary study was part of the exploratory outcomes of the COMBAT CF study protocol. Site-specific hospital Human Research Ethics Committee approved the COMBAT-CF trial and informed consent was obtained from parents\/guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}